Discovery and Characterization of Broadly Inhibitory Antibodies Targeting Severe Malaria Virulence Proteins

Two broadly reactive human monoclonal antibodies demonstrate the potential for developing effective treatments or vaccines against severe malaria by targeting a conserved region of virulence proteins essential for parasite binding and disease severity.